Statins and the risk of bleeding in patients taking dabigatran.

Bo-Lin HoYa-Ju LinSheng-Feng LinPing-Song ChouChien-Fu ChenRuey-Tay LinHan-Hwa HuA-Ching Chao

Published in: Acta neurologica Scandinavica (2019)

For secondary prevention of stroke in patients with NVAF who are taking dabigatran etexilate, co-prescription with a statin was associated with a lower risk of bleeding complications. Future research is needed to determine the pharmacological mechanism underlying this effect.

Keyphrases

atrial fibrillation
end stage renal disease
cardiovascular disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
type diabetes
coronary artery disease
risk factors